Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

FFF ENTERPRISES, INC.

Parent1 subsidiaryUEI: EMHFNF3LKVM6CAGE: 0T8N1

FFF ENTERPRISES, INC. is a federal contractor, registered under UEI EMHFNF3LKVM6 and CAGE code 0T8N1. It has been awarded $22,654,720 in federal contracts. Primary work spans Pharmaceutical Preparation Manufacturing, Drugs and Druggists' Sundries Merchant Wholesalers, and Unknown NAICS. Top awarding agencies include Department Of Veterans Affairs, Department Of Defense, and Department Of Homeland Security.

Contact Information

Registration and classification details

Registration

UEI Code

EMHFNF3LKVM6

CAGE Code

0T8N1

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

For Profit Organization

NAICS Codes

424210Drugs and Druggists' Sundries Merchant Wholesalers(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

FFF ENTERPRISES, INC. specializes in the manufacturing and supply of specialized biological products and pharmaceutical preparations for federal medical programs. Their core capabilities center on the production of therapeutic biologics, including antivenins for emergency medical use in national par...

FFF ENTERPRISES, INC. specializes in the manufacturing and supply of specialized biological products and pharmaceutical preparations for federal medical programs. Their core capabilities center on the production of therapeutic biologics, including antivenins for emergency medical use in national park clinics, and branded pharmaceuticals such as abaloparatide (TYMLOS), a parathyroid hormone-related peptide used in osteoporosis treatment. The company demonstrates technical proficiency in GMP-compliant manufacturing processes, cold chain logistics for sensitive biologics, and regulatory alignment with FDA standards for non-diagnostic biological and pharmaceutical products. Their ability to deliver mission-critical, time-sensitive therapeutics under strict quality control protocols distinguishes them as a reliable supplier for life-sustaining medical needs in remote or high-acuity federal settings. FFF ENTERPRISES, INC. has established direct contracting relationships with the Department of the Interior and the Department of Veterans Affairs. For the Interior Department, they provide specialized antivenins to support medical operations at national park clinics, addressing unique environmental health risks. With the Veterans Affairs system, they supply FDA-approved pharmaceuticals for chronic disease management, indicating a focus on veteran-specific therapeutic regimens. These engagements suggest a pattern of responsive, mission-aligned procurement where product specificity and regulatory integrity are paramount. The company’s primary industry focus lies in NAICS 325414 (biological product manufacturing) and 325412 (pharmaceutical preparation manufacturing), positioning them as a niche supplier of non-diagnostic biologics and branded prescription drugs. They serve the federal medical supply chain with precision-engineered therapeutics requiring stringent batch control, stability validation, and traceability—critical for federal health and safety missions. As a small business structured as a 2L entity based in Temecula, California, FFF ENTERPRISES, INC. operates without federal certifications but maintains a focused footprint in the federal pharmaceutical and biological supply market. Their geographic proximity to key logistics corridors supports efficient distribution to federal medical facilities across the western U.S.

Key Performance Metrics

Awards Count

293

All time

Active

1

Currently performing

Completed

292

Past period of performance

Total Awards

All time

Award Analytics & Distribution

Awards by Agency
Awards by NAICS
Awards by Agency Over Time
Awards by Place of Performance

Subsidiaries

1 company rolls up into FFF ENTERPRISES, INC., sized by each one's own awards

See all

Compete with FFF ENTERPRISES, INC.

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for FFF ENTERPRISES, INC.

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in FFF ENTERPRISES, INC.'s top NAICS codes and agencies

NAICS: 325412
New
DIBBS
Epinephrine Injector
Solicitation # SPE2D2-26-R-0009
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain is soliciting proposals for a national requirements contract for Epinephrine 0.3 MG/0.3 ML Auto-Injectors. This unrestricted, fully competitive acquisition is a firm-fixed-price contract consisting of a one-year base period with four one-year options. The resulting contract will establish a national supply source to provide these commercial items to the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons through DLA and VA prime vendor programs. The procurement is conducted under FAR Part 12 for commercial items, with a Lowest Price Technically Acceptable (LPTA) award basis. Proposals are evaluated based on technical requirements and past performance, with the award going to the responsible offeror providing the lowest evaluated aggregate price. The solicitation, numbered SPE2D2-26-R-0009, requires offerors to submit electronic proposals via the DIBBS portal by November 16, 2026. Key technical specifications include strict packaging requirements, such as the use of non-glass cylindrical bottles with a minimum 100cc volume, child-proof closures, and specific linear bar-coding conforming to GS1-128 or HIBC standards. All manufacturing facilities must comply with FDA current Good Manufacturing Practices (cGMP). The awarded contractor must be prepared to fill orders within 45 calendar days of award, with prices becoming effective within 60 days. Delivery is coordinated through separate business-to-business agreements with Pharmaceutical Prime Vendor distribution centers.
MEDICAL SUPPLY CHAIN FSGB

POSTED

about 12 hours ago

DEADLINE

in about 1 month
View Details
NAICS: 325412
New
DIBBS
Febuxostat Tablets
Solicitation # SPE2D2-26-R-0012
Solicitation SPE2D2-26-R-0012 is a requirements contract issued by the Defense Logistics Agency Troop Support Medical Supply Chain for the procurement of Febuxostat tablets in 30-count bottles. The requirement covers two strengths: 40mg and 80mg tablets. The acquisition is conducted as a Lowest Price Technically Acceptable (LPTA) procurement, where the award is granted to the responsible offeror who is determined to be technically acceptable and provides the lowest evaluated aggregate price. Technical acceptability is based on compliance with the Statement of Work and a review of past performance, including the status of FDA warning letters, violations, or failed inspections. The contract mandates strict adherence to FDA current Good Manufacturing Practice (cGMP) standards and requires products to have valid New Drug Applications (NDA) or Abbreviated New Drug Applications (ANDA), specifically preferring a Therapeutic Equivalence Code of A. Packaging must meet precise specifications, including a cylindrical bottle with a minimum 100cc volume, a 5.75-inch minimum circumference, and a child-proof safety cap. Labeling must be GS1-128 or HIBCC compliant and include linear bar coding at the unit-of-use level. Offers must be submitted exclusively through the Defense Logistics Agency Internet Bid Board System (DIBBS). Following several amendments, the final closing date for the receipt of offers is October 29, 2026, at 3:00 PM EST. Proposals must be organized into a non-price volume and a price proposal volume, including a Letter of Certification on manufacturer letterhead and specific FDA disclosures. The contract structure includes a base year and four option years, with an estimated base quantity of 76,388 bottles for the 40mg tablets.
Defense Logistics Agency

POSTED

about 12 hours ago

DEADLINE

in 15 days
View Details
NAICS: 325412
New
Federal
6505--Lab Supplies - Radiopharm Philadelphia VA Medical Center
Solicitation # 36C24427Q0018
The Department of Veterans Affairs Network Contracting Office 4 is soliciting quotations for an indefinite-quantity contract to provide radiopharmaceuticals and calibration sources for the Nuclear Medicine Department at the Corporal Michael J. Crescenz VA Medical Center in Philadelphia, Pennsylvania. The contract covers a base period from November 1, 2026, to October 31, 2031, with four additional option years. The selected vendor must be licensed and accredited by the Nuclear Regulatory Commission and comply with all regulations from the DOT, FDA, OSHA, and NHPP. Key deliverables include various cold kits and specific radiopharmaceuticals, with strict delivery requirements: routine orders must be received by 8:00 AM the following workday, and same-day orders must be delivered within two hours during normal business hours. The government will award the contract based on a comparative evaluation of price and past performance from the last three years, utilizing simplified acquisition procedures for commercial products. Technical requirements include specific labeling for radioactive materials and unit doses, as well as the provision of bar-labeled inserts for integration with the PineStar nuclear medicine information management system. If the contractor's system differs, they must provide data migration and training at no additional cost. Invoicing is to be submitted monthly and electronically via the Austin Payment Center. The solicitation is unrestricted, though price evaluation preference is provided for HUBZone small business concerns.
244-NETWORK Contract Office 4 (36C244)

POSTED

about 12 hours ago

DEADLINE

in about 19 hours
View Details